Curtis et al.'s exploration of LIPC in non-small cell lung carcinoma (NSCLC) indicated an adverse correlation between increased LIPC protein expression and worse prognosis and survival rates [25]. This evidence concerns the gene LIPC and non-small cell lung carcinoma.